MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12263-022-00704-z

Медицинская библиотека · Genes & nutrition · 2022

Mendelian randomization analysis of vitamin D in the secondary prevention of hypertensive-diabetic subjects: role of facilitating blood pressure control.

Chan Yap-Hang, Schooling C Mary, Zhao Jie V, Yeung Shiu-Lun Au, Hai Jo Jo, Thomas G Neil, Cheng Kar-Keung, Jiang Chao-Qiang, Wong Yuen-Kwun, Au Ka-Wing, Tang Clara S, Cheung Chloe Y Y, Xu Aimin, Sham Pak-Chung, Lam Tai-Hing, Lam Karen Siu-Ling, Tse Hung-Fat

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Vitamin D (Vit-D) promotes vascular repair and its deficiency is closely linked to the development of type 2 diabetes mellitus (T2DM) and hypertension. Whether genetially predicted vitamin D status (serological 25-hydroxyvitamin D [25(OH)D]) confers secondary protection against cardiovascular diseases (CVD) among high-risk hypertensive-diabetic subjects was unknown.

METHODS

This is a prospective, individual-data, two-sample Mendelian randomization study. We interrogated 12 prior GWAS-detected SNPs of comprehensive Vit-D mechanistic pathways using high-throughput exome chip analyses in a derivation subcohort (n = 1460) and constructed a genetic risk score (GRS) (rs2060793, rs4588, rs7041; F-statistic = 32, P < 0.001) for causal inference of comprehensive CVD hard clinical endpoints in an independent sample of hypertensive subjects (n = 3746) with prevailing co-morbid T2DM (79%) and serological 25(OH)D deficiency [< 20 ng/mL] 45%.

RESULTS

After 55.6 ± 28.9 months, 561 (15%) combined CVD events including myocardial infarction, unstable angina, ischemic stroke, congestive heart failure, peripheral vascular disease, and cardiovascular death had occurred. Kaplan-Meier analysis showed that genetically predicted reduced vitamin D status was associated with reduced event-free survival from combined CVD events (log-rank = 13.5, P = 0.001). Multivariate-adjusted per-allele increase in GRS predicted reduced combined CVD events (HR = 0.90 [0.84 to 0.96], P = 0.002). Mendelian randomization indicates that increased Vit-D exposure, leveraged through each 1 ng/mL genetically instrumented rise of serum Vit-D, protects against combined CVD events (Wald's estimate: OR = 0.86 [95%CI 0.75 to 0.95]), and myocardial infarction (OR = 0.76 [95%CI 0.60 to 0.90]). Furthermore, genetically predicted increase in Vit-D status ameliorates risk of deviation from achieving guideline-directed hypertension control (JNC-8: systolic target < 150 mmHg) (OR = 0.89 [95%CI 0.80 to 0.96]).

CONCLUSIONS

Genetically predicted increase in Vit-D status [25(OH)D] may confer secondary protection against incident combined CVD events and myocardial infarction in a hypertensive-diabetic population where serological 25(OH)D deficiency is common, through facilitating blood pressure control.

Для цитирования: Chan Yap-Hang, Schooling C Mary, Zhao Jie V, Yeung Shiu-Lun Au, Hai Jo Jo, Thomas G Neil, Cheng Kar-Keung, Jiang Chao-Qiang, Wong Yuen-Kwun, Au Ka-Wing, Tang Clara S, Cheung Chloe Y Y, Xu Aimin, Sham Pak-Chung, Lam Tai-Hing, Lam Karen Siu-Ling, Tse Hung-Fat. Mendelian randomization analysis of vitamin D in the secondary prevention of hypertensive-diabetic subjects: role of facilitating blood pressure control.. Genes & nutrition. 2022. DOI: 10.1186/s12263-022-00704-z.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.